Strs Ohio bought a new stake in Solventum Corporation (NYSE:SOLV – Free Report) during the 1st quarter, Holdings Channel.com reports. The firm bought 18,817 shares of the company’s stock, valued at approximately $1,431,000.
Other institutional investors have also recently bought and sold shares of the company. Rossby Financial LCC bought a new stake in Solventum in the 1st quarter valued at approximately $25,000. Strengthening Families & Communities LLC lifted its stake in Solventum by 376.8% in the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock valued at $25,000 after acquiring an additional 260 shares in the last quarter. Hara Capital LLC bought a new stake in Solventum in the 1st quarter valued at approximately $38,000. Smartleaf Asset Management LLC lifted its stake in Solventum by 193.4% in the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company’s stock valued at $40,000 after acquiring an additional 352 shares in the last quarter. Finally, Costello Asset Management INC bought a new stake in shares of Solventum during the 1st quarter worth approximately $42,000.
Get Solventum alerts:
Solventum Stock Performance
SOLV opened at $74.10 on Thursday. The firm has a market cap of $12.85 billion, a P/E ratio of 34.31, a price-to-earnings-growth ratio of 3.02 and a beta of 0.53. Solventum Corporation has a 52-week low of $60.70 and a 52-week high of $85.92. The company has a debt-to-equity ratio of 2.14, a quick ratio of 0.86 and a current ratio of 1.22. The business’s fifty day moving average is $73.01 and its 200-day moving average is $72.48.
Solventum (NYSE:SOLV – Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.24. The company had revenue of $2.16 billion for the quarter, compared to analyst estimates of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.Solventum’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Sell-side analysts expect that Solventum Corporation will post 6.58 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on SOLV. Wells Fargo & Company upped their price objective on Solventum from $79.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Monday. Zacks Research upgraded Solventum from a “hold” rating to a “strong-buy” rating in a research note on Monday. Wall Street Zen cut Solventum from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, September 9th. Argus upgraded Solventum from a “hold” rating to a “buy” rating and set a $90.00 price objective on the stock in a research note on Tuesday, July 1st. Finally, Jefferies Financial Group began coverage on Solventum in a research note on Thursday, September 11th. They set a “hold” rating and a $80.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Solventum currently has a consensus rating of “Hold” and a consensus price target of $85.44.
Read Our Latest Analysis on SOLV
About Solventum
(Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Stories
Five stocks we like better than Solventum
Large Cap Stock Definition and How to Invest
Biotech Breakouts: 3 Stocks With Massive Upside Potential
What is the Shanghai Stock Exchange Composite Index?
Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
Special Purpose Acquisition Company (SPAC) What You Need to Know
The Side of Rate Cuts Nobody Is Telling You About
Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Corporation (NYSE:SOLV – Free Report).